|
1
|
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.
|
Heart Rhythm
|
2012
|
8.03
|
|
2
|
Rhythm control versus rate control for atrial fibrillation and heart failure.
|
N Engl J Med
|
2008
|
6.17
|
|
3
|
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
|
Europace
|
2012
|
5.84
|
|
4
|
Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
|
J Am Coll Cardiol
|
2008
|
4.01
|
|
5
|
Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training.
|
Circulation
|
2010
|
3.72
|
|
6
|
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.
|
Circulation
|
2009
|
3.50
|
|
7
|
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
|
Can J Cardiol
|
2012
|
2.96
|
|
8
|
Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.
|
J Physiol
|
2007
|
2.83
|
|
9
|
Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation.
|
Circulation
|
2012
|
2.58
|
|
10
|
Recent advances in the molecular pathophysiology of atrial fibrillation.
|
J Clin Invest
|
2011
|
2.38
|
|
11
|
Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model.
|
J Am Coll Cardiol
|
2013
|
2.38
|
|
12
|
Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
|
Circ Arrhythm Electrophysiol
|
2008
|
2.37
|
|
13
|
Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve.
|
Circulation
|
2008
|
2.34
|
|
14
|
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
|
J Interv Card Electrophysiol
|
2012
|
2.08
|
|
15
|
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms.
|
Circ Res
|
2014
|
2.07
|
|
16
|
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure.
|
Cardiovasc Res
|
2004
|
2.06
|
|
17
|
Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model.
|
Cardiovasc Res
|
2005
|
2.02
|
|
18
|
Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
|
Cardiovasc Res
|
2007
|
2.02
|
|
19
|
Atrial fibrillation pathophysiology: implications for management.
|
Circulation
|
2011
|
2.01
|
|
20
|
Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function.
|
Circ Res
|
2002
|
2.00
|
|
21
|
Transmural action potential and ionic current remodeling in ventricles of failing canine hearts.
|
Am J Physiol Heart Circ Physiol
|
2002
|
2.00
|
|
22
|
Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation.
|
Biophys J
|
2005
|
1.96
|
|
23
|
Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation.
|
Circulation
|
2003
|
1.86
|
|
24
|
Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure.
|
J Mol Cell Cardiol
|
2007
|
1.85
|
|
25
|
Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation.
|
Circulation
|
2012
|
1.81
|
|
26
|
Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure.
|
Genes Dev
|
2006
|
1.80
|
|
27
|
Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation.
|
Cardiovasc Res
|
2010
|
1.74
|
|
28
|
Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure.
|
Heart Rhythm
|
2007
|
1.71
|
|
29
|
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence.
|
Eur Heart J
|
2005
|
1.71
|
|
30
|
Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
|
J Am Coll Cardiol
|
2013
|
1.68
|
|
31
|
Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy.
|
Circ Res
|
2014
|
1.68
|
|
32
|
Pulmonary vein reentry--properties and size matter: insights from a computational analysis.
|
Heart Rhythm
|
2007
|
1.68
|
|
33
|
Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study.
|
Heart Rhythm
|
2012
|
1.67
|
|
34
|
Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
|
Circulation
|
2005
|
1.67
|
|
35
|
Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium.
|
Am J Physiol Heart Circ Physiol
|
2005
|
1.65
|
|
36
|
New antiarrhythmic drugs for treatment of atrial fibrillation.
|
Lancet
|
2010
|
1.65
|
|
37
|
Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure.
|
Circulation
|
2004
|
1.64
|
|
38
|
Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences.
|
Circulation
|
2008
|
1.61
|
|
39
|
Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea.
|
Heart Rhythm
|
2012
|
1.59
|
|
40
|
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
|
Heart Rhythm
|
2010
|
1.59
|
|
41
|
Ca(2+)-related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm.
|
Circulation
|
2011
|
1.58
|
|
42
|
A proposal for new clinical concepts in the management of atrial fibrillation.
|
Am Heart J
|
2012
|
1.57
|
|
43
|
In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions.
|
Cardiovasc Res
|
2004
|
1.55
|
|
44
|
Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation.
|
J Am Coll Cardiol
|
2010
|
1.55
|
|
45
|
Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization.
|
Cardiovasc Res
|
2005
|
1.54
|
|
46
|
Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties.
|
Circ Res
|
2002
|
1.54
|
|
47
|
Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.
|
Heart Rhythm
|
2009
|
1.54
|
|
48
|
Differences in atrial fibrillation properties under vagal nerve stimulation versus atrial tachycardia remodeling.
|
Heart Rhythm
|
2009
|
1.53
|
|
49
|
Molecular basis of funny current (If) in normal and failing human heart.
|
J Mol Cell Cardiol
|
2008
|
1.53
|
|
50
|
Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog.
|
Circulation
|
2013
|
1.51
|
|
51
|
Atrial fibrillation-associated remodeling does not promote atrial thrombus formation in canine models.
|
Circ Arrhythm Electrophysiol
|
2012
|
1.50
|
|
52
|
MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation.
|
J Clin Invest
|
2013
|
1.49
|
|
53
|
Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.49
|
|
54
|
Involvement of lipid rafts and caveolae in cardiac ion channel function.
|
Cardiovasc Res
|
2006
|
1.48
|
|
55
|
Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation.
|
Heart Rhythm
|
2012
|
1.47
|
|
56
|
Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.
|
Circ Res
|
2014
|
1.47
|
|
57
|
Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: a clinical-experimental correlation.
|
Heart Rhythm
|
2011
|
1.45
|
|
58
|
Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties.
|
J Physiol
|
2003
|
1.45
|
|
59
|
Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice.
|
Cardiovasc Res
|
2011
|
1.44
|
|
60
|
Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts.
|
J Physiol
|
2004
|
1.44
|
|
61
|
HERG K+ channel, a regulator of tumor cell apoptosis and proliferation.
|
Cancer Res
|
2002
|
1.43
|
|
62
|
Cellular properties of C-terminal KCNH2 long QT syndrome mutations: description and divergence from clinical phenotypes.
|
Heart Rhythm
|
2008
|
1.43
|
|
63
|
Novel molecular targets for atrial fibrillation therapy.
|
Nat Rev Drug Discov
|
2012
|
1.42
|
|
64
|
Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs.
|
Circulation
|
2004
|
1.41
|
|
65
|
Comparison of ion-channel subunit expression in canine cardiac Purkinje fibers and ventricular muscle.
|
Circ Res
|
2002
|
1.41
|
|
66
|
Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts.
|
J Mol Cell Cardiol
|
2010
|
1.37
|
|
67
|
A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?
|
J Physiol
|
2002
|
1.35
|
|
68
|
MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation.
|
Circulation
|
2013
|
1.33
|
|
69
|
Novel approaches for pharmacological management of atrial fibrillation.
|
Drugs
|
2009
|
1.32
|
|
70
|
Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs.
|
Circulation
|
2002
|
1.31
|
|
71
|
Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia.
|
Circulation
|
2008
|
1.30
|
|
72
|
Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
|
Circ Res
|
2009
|
1.29
|
|
73
|
Potassium channel subunit remodeling in rabbits exposed to long-term bradycardia or tachycardia: discrete arrhythmogenic consequences related to differential delayed-rectifier changes.
|
Circulation
|
2006
|
1.27
|
|
74
|
G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.
|
J Physiol
|
2011
|
1.27
|
|
75
|
Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current.
|
Circ Res
|
2008
|
1.27
|
|
76
|
Molecular basis of species-specific expression of repolarizing K+ currents in the heart.
|
Am J Physiol Heart Circ Physiol
|
2003
|
1.27
|
|
77
|
Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias.
|
Circulation
|
2006
|
1.26
|
|
78
|
Connexins and atrial fibrillation: filling in the gaps.
|
Circulation
|
2011
|
1.26
|
|
79
|
Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways.
|
Cardiovasc Res
|
2003
|
1.25
|
|
80
|
Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.
|
J Biol Chem
|
2010
|
1.24
|
|
81
|
Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets.
|
J Cardiovasc Electrophysiol
|
2002
|
1.24
|
|
82
|
Funny current downregulation and sinus node dysfunction associated with atrial tachyarrhythmia: a molecular basis for tachycardia-bradycardia syndrome.
|
Circulation
|
2009
|
1.23
|
|
83
|
Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins.
|
Circulation
|
2010
|
1.23
|
|
84
|
Membrane cholesterol modulates Kv1.5 potassium channel distribution and function in rat cardiomyocytes.
|
J Physiol
|
2007
|
1.22
|
|
85
|
Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling.
|
Cardiovasc Res
|
2007
|
1.22
|
|
86
|
Induction of heat shock response protects the heart against atrial fibrillation.
|
Circ Res
|
2006
|
1.20
|
|
87
|
Animal models for atrial fibrillation: clinical insights and scientific opportunities.
|
Europace
|
2009
|
1.20
|
|
88
|
Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man.
|
J Mol Cell Cardiol
|
2005
|
1.20
|
|
89
|
Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.
|
Circ Arrhythm Electrophysiol
|
2012
|
1.20
|
|
90
|
Differential distribution of Kir2.1 and Kir2.3 subunits in canine atrium and ventricle.
|
Am J Physiol Heart Circ Physiol
|
2002
|
1.18
|
|
91
|
Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.
|
Br J Pharmacol
|
2004
|
1.17
|
|
92
|
Characterization of the in vivo and in vitro electrophysiological effects of the novel antiarrhythmic agent AZD7009 in atrial and ventricular tissue of the dog.
|
J Cardiovasc Pharmacol
|
2006
|
1.17
|
|
93
|
Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs.
|
J Physiol
|
2013
|
1.17
|
|
94
|
Contrasting gene expression profiles in two canine models of atrial fibrillation.
|
Circ Res
|
2007
|
1.16
|
|
95
|
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
|
Can J Cardiol
|
2011
|
1.16
|
|
96
|
Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2.
|
Am J Physiol Cell Physiol
|
2005
|
1.16
|
|
97
|
Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.
|
J Cardiovasc Pharmacol
|
2008
|
1.15
|
|
98
|
Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium.
|
J Physiol
|
2004
|
1.14
|
|
99
|
Time-dependent transients in an ionically based mathematical model of the canine atrial action potential.
|
Am J Physiol Heart Circ Physiol
|
2002
|
1.14
|
|
100
|
Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.
|
Circulation
|
2007
|
1.14
|
|
101
|
Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model.
|
Circ Res
|
2005
|
1.13
|
|
102
|
Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.
|
Cardiovasc Res
|
2008
|
1.13
|
|
103
|
Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles.
|
Heart Rhythm
|
2004
|
1.12
|
|
104
|
Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure.
|
Cardiovasc Res
|
2002
|
1.12
|
|
105
|
Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents.
|
Cardiovasc Res
|
2003
|
1.12
|
|
106
|
Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure.
|
J Mol Cell Cardiol
|
2004
|
1.11
|
|
107
|
KvLQT1 modulates the distribution and biophysical properties of HERG. A novel alpha-subunit interaction between delayed rectifier currents.
|
J Biol Chem
|
2003
|
1.11
|
|
108
|
Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator.
|
J Biol Chem
|
2004
|
1.10
|
|
109
|
Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles.
|
Am J Physiol Heart Circ Physiol
|
2006
|
1.09
|
|
110
|
Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure.
|
Circulation
|
2004
|
1.09
|
|
111
|
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation.
|
J Mol Cell Cardiol
|
2008
|
1.09
|
|
112
|
Atrial ischemia promotes atrial fibrillation in dogs.
|
Circulation
|
2003
|
1.08
|
|
113
|
Clinical and mechanistic issues in early repolarization of normal variants and lethal arrhythmia syndromes.
|
J Am Coll Cardiol
|
2010
|
1.07
|
|
114
|
Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
|
Circulation
|
2003
|
1.06
|
|
115
|
Atrial fibrillation: basic mechanisms, remodeling and triggers.
|
J Interv Card Electrophysiol
|
2005
|
1.05
|
|
116
|
Atrial tachycardia remodeling of pulmonary vein cardiomyocytes: comparison with left atrium and potential relation to arrhythmogenesis.
|
Circulation
|
2005
|
1.05
|
|
117
|
Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model.
|
Cardiovasc Res
|
2011
|
1.05
|
|
118
|
MicroRNA regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential.
|
Circ Res
|
2014
|
1.05
|
|
119
|
Role of KATP channels in the maintenance of ventricular fibrillation in cardiomyopathic human hearts.
|
Circ Res
|
2011
|
1.05
|
|
120
|
Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.05
|
|
121
|
Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
|
Circ Res
|
2008
|
1.03
|
|
122
|
Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
|
Circulation
|
2007
|
1.02
|
|
123
|
Tissue-specific expression of two human Ca(v)1.2 isoforms under the control of distinct 5' flanking regulatory elements.
|
FEBS Lett
|
2003
|
1.02
|
|
124
|
Spotlight on atrial fibrillation-the 'complete arrhythmia'.
|
Cardiovasc Res
|
2002
|
1.01
|
|
125
|
Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes.
|
Cardiovasc Res
|
2007
|
1.01
|
|
126
|
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.
|
Europace
|
2009
|
1.01
|
|
127
|
Unique cardiac Purkinje fiber transient outward current β-subunit composition: a potential molecular link to idiopathic ventricular fibrillation.
|
Circ Res
|
2013
|
1.00
|
|
128
|
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.
|
Eur Heart J
|
2009
|
1.00
|
|
129
|
Role of inflammation in atrial fibrillation pathophysiology and management.
|
Circ J
|
2015
|
0.99
|
|
130
|
Atrial fibrillation: evidence for genetically determined disease.
|
Curr Opin Cardiol
|
2008
|
0.99
|
|
131
|
Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure.
|
J Mol Cell Cardiol
|
2010
|
0.99
|
|
132
|
Kir2.4 and Kir2.1 K(+) channel subunits co-assemble: a potential new contributor to inward rectifier current heterogeneity.
|
J Physiol
|
2002
|
0.98
|
|
133
|
Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction.
|
Heart Rhythm
|
2009
|
0.98
|
|
134
|
Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential.
|
J Physiol
|
2012
|
0.98
|
|
135
|
Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
|
Curr Opin Cardiol
|
2009
|
0.98
|
|
136
|
Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia.
|
Cardiovasc Res
|
2008
|
0.98
|
|
137
|
A clinical approach to early repolarization.
|
Circulation
|
2013
|
0.98
|
|
138
|
Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model.
|
Circulation
|
2011
|
0.98
|
|
139
|
Properties of potassium currents in Purkinje cells of failing human hearts.
|
Am J Physiol Heart Circ Physiol
|
2002
|
0.97
|
|
140
|
Pulmonary vein isolation using a pace-capture-guided versus an adenosine-guided approach: effect on dormant conduction and long-term freedom from recurrent atrial fibrillation--a prospective study.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.97
|
|
141
|
New insights into the mechanisms and management of atrial fibrillation.
|
CMAJ
|
2002
|
0.96
|
|
142
|
Canine ventricular KCNE2 expression resides predominantly in Purkinje fibers.
|
Circ Res
|
2003
|
0.96
|
|
143
|
Atrial-selective approaches for the treatment of atrial fibrillation.
|
J Am Coll Cardiol
|
2008
|
0.96
|
|
144
|
Comparison of ion channel distribution and expression in cardiomyocytes of canine pulmonary veins versus left atrium.
|
Cardiovasc Res
|
2005
|
0.96
|
|
145
|
Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates.
|
Am J Physiol Heart Circ Physiol
|
2008
|
0.96
|
|
146
|
Cellular electrophysiology of atrial fibrillation.
|
Cardiovasc Res
|
2002
|
0.96
|
|
147
|
Dofetilide block involves interactions with open and inactivated states of HERG channels.
|
Pflugers Arch
|
2001
|
0.95
|
|
148
|
Impact of tissue geometry on simulated cholinergic atrial fibrillation: a modeling study.
|
Chaos
|
2011
|
0.94
|
|
149
|
Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs.
|
Cardiovasc Res
|
2006
|
0.94
|
|
150
|
Normal function of HERG K+ channels expressed in HEK293 cells requires basal protein kinase B activity.
|
FEBS Lett
|
2003
|
0.94
|
|
151
|
A high-fat diet increases risk of ventricular arrhythmia in female rats: enhanced arrhythmic risk in the absence of obesity or hyperlipidemia.
|
J Appl Physiol (1985)
|
2010
|
0.93
|
|
152
|
The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome.
|
Circ Arrhythm Electrophysiol
|
2009
|
0.93
|
|
153
|
Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes.
|
Cardiovasc Res
|
2011
|
0.93
|
|
154
|
Roles of the left atrial roof and pulmonary veins in the anatomic substrate for persistent atrial fibrillation and ablation in a canine model.
|
J Am Coll Cardiol
|
2010
|
0.91
|
|
155
|
The effect of vagally induced dispersion of action potential duration on atrial arrhythmogenesis.
|
Heart Rhythm
|
2004
|
0.90
|
|
156
|
Differential protein kinase C isoform regulation and increased constitutive activity of acetylcholine-regulated potassium channels in atrial remodeling.
|
Circ Res
|
2011
|
0.90
|
|
157
|
Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.
|
Drugs
|
2010
|
0.90
|
|
158
|
Congestive heart failure effects on atrial fibroblast phenotype: differences between freshly-isolated and cultured cells.
|
PLoS One
|
2012
|
0.90
|
|
159
|
Differential alterations of receptor densities of three muscarinic acetylcholine receptor subtypes and current densities of the corresponding K+ channels in canine atria with atrial fibrillation induced by experimental congestive heart failure.
|
Cell Physiol Biochem
|
2004
|
0.90
|
|
160
|
Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation.
|
J Mol Cell Cardiol
|
2008
|
0.90
|
|
161
|
Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
|
Cardiovasc Res
|
2008
|
0.90
|
|
162
|
C-terminal domain of Kv4.2 and associated KChIP2 interactions regulate functional expression and gating of Kv4.2.
|
J Biol Chem
|
2006
|
0.89
|
|
163
|
Heat shock proteins as molecular targets for intervention in atrial fibrillation.
|
Cardiovasc Res
|
2008
|
0.89
|
|
164
|
A single residue in the S6 transmembrane domain governs the differential flecainide sensitivity of voltage-gated potassium channels.
|
Mol Pharmacol
|
2005
|
0.89
|
|
165
|
Ion channel subunit expression changes in cardiac Purkinje fibers: a potential role in conduction abnormalities associated with congestive heart failure.
|
Circ Res
|
2009
|
0.89
|
|
166
|
Single-channel recordings of a rapid delayed rectifier current in adult mouse ventricular myocytes: basic properties and effects of divalent cations.
|
J Physiol
|
2004
|
0.89
|
|
167
|
Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
|
Circulation
|
2013
|
0.88
|
|
168
|
Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines.
|
Br J Pharmacol
|
2003
|
0.88
|
|
169
|
Effects of heart disease on cardiac ion current density versus current amplitude: important conceptual subtleties in the language of arrhythmogenic ion channel remodeling.
|
Circ Res
|
2008
|
0.88
|
|
170
|
Atrial repolarization alternans as a path to atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2012
|
0.87
|
|
171
|
Interactions between cardiac fibrosis spatial pattern and ionic remodeling on electrical wave propagation.
|
Conf Proc IEEE Eng Med Biol Soc
|
2011
|
0.87
|
|
172
|
Pharmacological elimination of motion artifacts during optical imaging of cardiac tissues: is blebbistatin the answer?
|
Heart Rhythm
|
2007
|
0.87
|
|
173
|
Atrial fibrillation compendium: historical context and detailed translational perspective on an important clinical problem.
|
Circ Res
|
2014
|
0.87
|
|
174
|
Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model.
|
PLoS One
|
2013
|
0.87
|
|
175
|
Local delivery of 17beta-estradiol improves reendothelialization and decreases inflammation after coronary stenting in a porcine model.
|
Thromb Haemost
|
2005
|
0.86
|
|
176
|
Novel anti-arrhythmic drugs for atrial fibrillation management.
|
Curr Vasc Pharmacol
|
2007
|
0.86
|
|
177
|
Cardiac pathways distinguish two epistatic modules enacting BP quantitative trait loci and candidate gene analysis.
|
Hypertens Res
|
2009
|
0.86
|
|
178
|
Stem cells are not proarrhythmic: letting the genie out of the bottle.
|
Circulation
|
2009
|
0.86
|
|
179
|
Effects of sustained beta-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes.
|
Am J Physiol Heart Circ Physiol
|
2002
|
0.85
|
|
180
|
Wave block formation in homogeneous excitable media following premature excitations: dependence on restitution relations.
|
Phys Rev E Stat Nonlin Soft Matter Phys
|
2005
|
0.85
|
|
181
|
Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases.
|
Eur Heart J
|
2008
|
0.85
|
|
182
|
New insights into the molecular basis of atrial fibrillation: mechanistic and therapeutic implications.
|
Cardiovasc Res
|
2011
|
0.84
|
|
183
|
In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics.
|
Biophys J
|
2012
|
0.84
|
|
184
|
Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling.
|
Cardiovasc Res
|
2002
|
0.84
|
|
185
|
Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction.
|
J Pharmacol Exp Ther
|
2007
|
0.84
|
|
186
|
Potential mechanisms for the enhancement of HERG K+ channel function by phospholipid metabolites.
|
Br J Pharmacol
|
2004
|
0.84
|
|
187
|
Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure.
|
J Mol Cell Cardiol
|
2008
|
0.84
|
|
188
|
Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca²⁺ in adult cardiac myocytes.
|
J Mol Cell Cardiol
|
2013
|
0.83
|
|
189
|
The Kv4.2 N-terminal restores fast inactivation and confers KChlP2 modulatory effects on N-terminal-deleted Kv1.4 channels.
|
Pflugers Arch
|
2004
|
0.83
|
|
190
|
CrossTalk proposal: Prolonged intense exercise training does lead to myocardial damage.
|
J Physiol
|
2013
|
0.83
|
|
191
|
Proarrhythmic atrial calcium cycling in the diseased heart.
|
Adv Exp Med Biol
|
2012
|
0.83
|
|
192
|
Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors.
|
J Mol Cell Cardiol
|
2013
|
0.82
|
|
193
|
Differential interactions of Na+ channel toxins with T-type Ca2+ channels.
|
J Gen Physiol
|
2008
|
0.82
|
|
194
|
Calcium handling and atrial fibrillation.
|
Wien Med Wochenschr
|
2012
|
0.82
|
|
195
|
Adenosine following pulmonary vein isolation to target dormant conduction elimination (ADVICE): methods and rationale.
|
Can J Cardiol
|
2012
|
0.82
|
|
196
|
Voltage-clamp-based methods for the detection of constitutively active acetylcholine-gated I(K,ACh) channels in the diseased heart.
|
Methods Enzymol
|
2010
|
0.82
|
|
197
|
Characterization of the cardiac KCNE1 gene promoter.
|
Cardiovasc Res
|
2006
|
0.82
|
|
198
|
Defining "culprit mechanisms" in arrhythmogenic cardiac remodeling.
|
Circ Res
|
2004
|
0.82
|
|
199
|
Exchange protein directly activated by cAMP mediates slow delayed-rectifier current remodeling by sustained β-adrenergic activation in guinea pig hearts.
|
Circ Res
|
2014
|
0.82
|
|
200
|
Predicting the entrainment of reentrant cardiac waves using phase resetting curves.
|
Phys Rev E Stat Nonlin Soft Matter Phys
|
2002
|
0.81
|
|
201
|
Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes.
|
Am J Physiol Renal Physiol
|
2013
|
0.81
|
|
202
|
Comparison of Ca2+-handling properties of canine pulmonary vein and left atrial cardiomyocytes.
|
Am J Physiol Heart Circ Physiol
|
2006
|
0.81
|
|
203
|
The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
|
Cardiovasc Res
|
2007
|
0.81
|
|
204
|
Anthrax lethal factor activates K(+) channels to induce IL-1β secretion in macrophages.
|
J Immunol
|
2011
|
0.81
|
|
205
|
Atrial fibrillation: therapy with omega-3 fatty acids-is the case closed?
|
Nat Rev Cardiol
|
2011
|
0.81
|
|
206
|
Remodeling of Ca(2+)-handling by atrial tachycardia: evidence for a role in loss of rate-adaptation.
|
Cardiovasc Res
|
2002
|
0.81
|
|
207
|
Distinct genomic replacements from Lewis correct diastolic dysfunction, attenuate hypertension, and reduce left ventricular hypertrophy in Dahl salt-sensitive rats.
|
J Hypertens
|
2008
|
0.81
|
|
208
|
Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.81
|
|
209
|
The role of pulmonary veins vs. autonomic ganglia in different experimental substrates of canine atrial fibrillation.
|
Cardiovasc Res
|
2010
|
0.81
|
|
210
|
Adenosine testing in atrial flutter ablation: unmasking of dormant conduction across the cavotricuspid isthmus and risk of recurrence.
|
J Cardiovasc Electrophysiol
|
2013
|
0.81
|
|
211
|
Association of neonatal hypoxia with lasting changes in left ventricular gene expression: an animal model.
|
J Thorac Cardiovasc Surg
|
2009
|
0.81
|
|
212
|
Identification of atrial tissue in pulmonary veins using intravascular ultrasound.
|
J Am Soc Echocardiogr
|
2003
|
0.80
|
|
213
|
Exercise training as a treatment for heart failure: potential mechanisms and clinical implications.
|
J Physiol
|
2009
|
0.80
|
|
214
|
Atrial structural remodeling as an antiarrhythmic target.
|
J Cardiovasc Pharmacol
|
2008
|
0.80
|
|
215
|
The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
|
J Cardiovasc Pharmacol
|
2015
|
0.80
|
|
216
|
AMP-activated protein kinase: potential role in cardiac electrophysiology and arrhythmias.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.80
|
|
217
|
G-protein signaling and arrhythmogenic atrial remodeling: relevance to novel therapeutic targets in atrial fibrillation.
|
Heart Rhythm
|
2008
|
0.80
|
|
218
|
Properties of a time-dependent potassium current in pig atrium: evidence for a role of kv1.5 in repolarization.
|
J Pharmacol Exp Ther
|
2006
|
0.80
|
|
219
|
Age, gender, and supraventricular arrhythmias: roles of ion channels, connexins, and tissue architecture?
|
Heart Rhythm
|
2004
|
0.80
|
|
220
|
Rate-dependence of atrial tachycardia effects on atrial refractoriness and atrial fibrillation maintenance.
|
Cardiovasc Res
|
2008
|
0.79
|
|
221
|
Hypoxia in early life is associated with lasting changes in left ventricular structure and function at maturity in the rat.
|
Int J Cardiol
|
2010
|
0.79
|
|
222
|
Management of atrial fibrillation in the year 2033: new concepts, tools, and applications leading to personalized medicine.
|
Can J Cardiol
|
2013
|
0.79
|
|
223
|
Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes.
|
Cardiovasc Res
|
2007
|
0.79
|
|
224
|
Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block.
|
Europace
|
2007
|
0.79
|
|
225
|
Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.
|
Pacing Clin Electrophysiol
|
2003
|
0.78
|
|
226
|
Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy.
|
J Mol Cell Cardiol
|
2008
|
0.78
|
|
227
|
Development of a computer algorithm for the detection of phase singularities and initial application to analyze simulations of atrial fibrillation.
|
Chaos
|
2002
|
0.78
|
|
228
|
Arrhythmogenic right ventricular dysplasia type 1 and mutations in transforming growth factor beta3 gene regulatory regions: a breakthrough?
|
Cardiovasc Res
|
2005
|
0.78
|
|
229
|
Drugs to promote sinus rhythm reversion and maintenance in atrial fibrillation--why amiodarone is better.
|
Cardiovasc Drugs Ther
|
2003
|
0.78
|
|
230
|
T-type calcium current contributes to escape automaticity and governs the occurrence of lethal arrhythmias after atrioventricular block in mice.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.78
|
|
231
|
Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate.
|
Circulation
|
2002
|
0.78
|
|
232
|
Pulmonary vein cellular electrophysiology and atrial fibrillation: does basic research help us understand clinical pulmonary-vein arrhythmogenesis?
|
Heart Rhythm
|
2005
|
0.78
|
|
233
|
Consequences of Atrial or Ventricular Tachypacing on the Heat Shock Proteins (HSP) level of Expression and Phosphorylation.
|
Mcgill J Med
|
2009
|
0.78
|
|
234
|
Dormant pulmonary vein conduction unmasked by external electrical cardioversion.
|
Heart Rhythm
|
2009
|
0.78
|
|
235
|
A mathematical model of human atrioventricular nodal function incorporating concealed conduction.
|
Bull Math Biol
|
2002
|
0.78
|
|
236
|
Aldosterone antagonism and atrial fibrillation: time for clinical assessment?
|
Eur Heart J
|
2005
|
0.77
|
|
237
|
Physiological versus pathological cardiac electrical remodelling: potential basis and relevance to clinical management.
|
J Physiol
|
2010
|
0.77
|
|
238
|
Ultrarapid delayed rectifier K(+) current in H9c2 rat ventricular cell line: biophysical property and molecular identity.
|
Cell Physiol Biochem
|
2002
|
0.77
|
|
239
|
Remodeling of cardiac inward-rectifier currents: an often-overlooked contributor to arrhythmogenic states.
|
J Mol Cell Cardiol
|
2003
|
0.77
|
|
240
|
Human genetics: Lost anchors cost lives.
|
Nature
|
2003
|
0.77
|
|
241
|
Isolation and study of cardiac nuclei from canine myocardium and adult ventricular myocytes.
|
Methods Mol Biol
|
2015
|
0.77
|
|
242
|
Inward rectifier-funny current balance and spontaneous automaticity: cautionary notes for biologic pacemaker development.
|
Heart Rhythm
|
2008
|
0.77
|
|
243
|
Novel targets for cardiac antiarrhythmic drug development.
|
Curr Pharm Des
|
2005
|
0.77
|
|
244
|
Exercise training, inflammation and heart failure: working out to cool down.
|
J Physiol
|
2010
|
0.77
|
|
245
|
Dronedarone in atrial fibrillation--Jekyll and Hyde?
|
N Engl J Med
|
2011
|
0.77
|
|
246
|
Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
|
Pacing Clin Electrophysiol
|
2009
|
0.76
|
|
247
|
Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
|
J Cardiovasc Electrophysiol
|
2004
|
0.76
|
|
248
|
F 16915 prevents heart failure-induced atrial fibrillation: a promising new drug as upstream therapy.
|
Naunyn Schmiedebergs Arch Pharmacol
|
2014
|
0.76
|
|
249
|
Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat.
|
J Cell Physiol
|
2015
|
0.76
|
|
250
|
Driver regions in atrial fibrillation associated with congestive heart failure: where are they, and what are they telling us?
|
J Cardiovasc Electrophysiol
|
2005
|
0.76
|
|
251
|
Unique quantitative trait loci in synergy permanently improve diastolic dysfunction.
|
Can J Cardiol
|
2013
|
0.76
|
|
252
|
Electrical storm: recent pathophysiological insights and therapeutic consequences.
|
Basic Res Cardiol
|
2013
|
0.76
|
|
253
|
Prognostic significance of ventricular arrhythmias post-myocardial infarction.
|
Can J Cardiol
|
2003
|
0.76
|
|
254
|
Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.
|
Expert Rev Cardiovasc Ther
|
2015
|
0.75
|
|
255
|
Reply: Of mice and men: atrial fibrillation in veteran endurance runners.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
256
|
Rebuttal from Eduard Guasch and Stanley Nattel.
|
J Physiol
|
2013
|
0.75
|
|
257
|
Teasing out circadian variability in heart rate turbulence: A new approach to detecting biorhythms underlying cardiac function.
|
Heart Rhythm
|
2006
|
0.75
|
|
258
|
Photoreleasable ligands to study intracrine angiotensin II signalling.
|
J Physiol
|
2015
|
0.75
|
|
259
|
Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome.
|
Heart Rhythm
|
2005
|
0.75
|
|
260
|
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
|
Can J Cardiol
|
2008
|
0.75
|
|
261
|
Inappropriate sinus tachycardia and beta-receptor autoantibodies: a mechanistic breakthrough?
|
Heart Rhythm
|
2006
|
0.75
|
|
262
|
Looking into the left atrial crystal ball: a ray of hope for patients with organic mitral regurgitation.
|
J Am Coll Cardiol
|
2010
|
0.75
|
|
263
|
Role of constitutively active acetylcholine-mediated potassium current in atrial contractile dysfunction caused by atrial tachycardia remodelling.
|
Europace
|
2010
|
0.75
|
|
264
|
Repolarization indices or calcium-current recovery/repolarization balance: what determines torsadogenesis?
|
Heart Rhythm
|
2007
|
0.75
|
|
265
|
Fast and furious: new ways to think about, study and treat cardiac arrhythmias.
|
J Physiol
|
2009
|
0.75
|
|
266
|
Triggering of cardiac arrhythmic events in long QT syndrome: lessons from funny bunnies.
|
J Physiol
|
2012
|
0.75
|
|
267
|
Regional discrepancies in ionic currents and arrhythmia susceptibility: clinical relevance.
|
Heart Rhythm
|
2005
|
0.75
|
|
268
|
Preoperative atrial cardiomyocyte ionic currents and postoperative AF: important insights into what is not the mechanism.
|
J Cardiovasc Electrophysiol
|
2006
|
0.75
|
|
269
|
Adenosine and atrial arrhythmias: exploring electrophysiological mechanisms in vivo.
|
Pacing Clin Electrophysiol
|
2012
|
0.75
|
|
270
|
Ventricular tachyarrhythmia induction by strong cardiac shocks: can understanding underlying mechanisms lead to improved prevention of defibrillator failure?
|
Heart Rhythm
|
2006
|
0.75
|
|
271
|
The interaction between delayed rectifier channel alpha-subunits does not involve hetero-tetramer formation.
|
Naunyn Schmiedebergs Arch Pharmacol
|
2015
|
0.75
|
|
272
|
Arrhythmias in 2015: Advances in drug, ablation, and device therapy for cardiac arrhythmias.
|
Nat Rev Cardiol
|
2016
|
0.75
|
|
273
|
Concealed automaticity from an island of atrial myocardium post cavotricuspid ablation.
|
J Cardiovasc Electrophysiol
|
2010
|
0.75
|
|
274
|
Atrial fibrillation: basic and clinical research at the Montreal Heart Institute.
|
Can J Cardiol
|
2005
|
0.75
|
|
275
|
Inefficacy of a highly selective T-type calcium channel blocker in preventing atrial fibrillation related remodeling.
|
J Cardiovasc Electrophysiol
|
2014
|
0.75
|
|
276
|
Inflammation and biomarkers in vascular disease: emerging insights and opportunities.
|
Can J Cardiol
|
2012
|
0.75
|
|
277
|
Evolving developments in the therapeutics of atrial fibrillation: addressing an unmet need.
|
J Cardiovasc Pharmacol
|
2008
|
0.75
|
|
278
|
Late pulmonary vein reconnection: insights into mechanisms of atrial fibrillation recurrence after pulmonary vein isolation.
|
Europace
|
2013
|
0.75
|
|
279
|
A proud tradition and a new beginning with a theme issue on atrial fibrillation.
|
Can J Cardiol
|
2011
|
0.75
|
|
280
|
A focus on hypertension: a modest condition of enormous significance.
|
Can J Cardiol
|
2011
|
0.75
|
|
281
|
JAK-STAT signaling and the atrial fibrillation promoting fibrotic substrate.
|
Cardiovasc Res
|
2017
|
0.75
|
|
282
|
The pathology of atrial fibrillation in dogs.
|
J Vet Cardiol
|
2005
|
0.75
|
|
283
|
Case studies with the experts: management decisions in atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2008
|
0.75
|
|
284
|
Canadian Journal of Cardiology January 2013: genetics and more.
|
Can J Cardiol
|
2013
|
0.75
|
|
285
|
[Anchoring proteins and cardiac sudden death: how and why?].
|
Med Sci (Paris)
|
2004
|
0.75
|
|
286
|
Anticoagulation for atrial fibrillation: state of the art and recommendations for a quickly moving target.
|
Can J Cardiol
|
2013
|
0.75
|
|
287
|
Combining distinctive and novel loci doubles BP reduction, reverses diastolic dysfunction and mitigates LV hypertrophy.
|
J Hypertens
|
2013
|
0.75
|
|
288
|
Corticosteroid use during pulmonary vein isolation is associated with a higher prevalence of dormant pulmonary vein conduction.
|
Heart Rhythm
|
2013
|
0.75
|